However, because participants in that trial were receiving background oral therapy and had established diabetes, treatment responses may differ in newly diagnosed, treatment-nave individuals
One study comparing adverse event profiles found that semaglutide users reported slightly higher rates of fatigue, while tirzepatide users reported slightly higher rates of injection site reactions
Before starting Semaneo 0.25mg Injection Combipack, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems
It is important to note that there is no established link between Mounjaro and increased dental complications such as tooth decay, gum disease, or delayed wound healing
Semaglutide is administered subcutaneously once a week with dosage guidelines that can vary between 1.7mg per week and 2.4mg per week
How do I manage constipation on GLP-1 medications